Characteristic Evaluation of a <sup>11</sup>C-Labeled Leucine Analog, <scp>l</scp>-α-[5-<sup>11</sup>C]methylleucine, as a Tracer for Brain Tumor Imaging by Positron Emission Tomography-Reference-Cited by-同舟云学术

Characteristic Evaluation of a ¹¹C-Labeled Leucine Analog, l-α-[5-¹¹C]methylleucine, as a Tracer for Brain Tumor Imaging by Positron Emission Tomography

Published:2023-02-20 Issue:3 Volume:20 Page:1842-1849
ISSN:1543-8384
Container-title:Molecular Pharmaceutics
language:en
Short-container-title:Mol. Pharmaceutics

Author:

Tahara Tsuyoshi¹²³^ORCID,Takatani Shuhei¹²,Tsuji Mieko²,Shibata Nina²,Hosaka Nami¹²,Inoue Michiko¹²,Ohno Masahiro¹²,Ozaki Daiki²,Mawatari Aya¹²,Watanabe Yasuyoshi¹²,Doi Hisashi¹²^ORCID,Onoe Hirotaka¹²⁴

Affiliation:

1. RIKEN Center for Biosystems Dynamics Research, 6-7-3 Minatojima Minamimachi, Chuo-ku, Kobe, Hyogo 650-0047, Japan

2. RIKEN Center for Life Science Technologies, 6-7-3 Minatojima Minamimachi, Chuo-ku, Kobe, Hyogo 650-0047, Japan

3. Department of In Vivo Imaging, Tokushima University, 3-18-15 Kuramoto-Cho, Tokushima, Tokushima 770-8503, Japan

4. Human Brain Research Center, Graduate School of Medicine, Kyoto University, 54 Shogoin-Kawahara-Cho, Sakyo-ku, Kyoto 606-8507, Japan

Funder

Ministry of Education, Culture, Sports, Science and Technology

Publisher

American Chemical Society (ACS)

Subject

Drug Discovery,Pharmaceutical Science,Molecular Medicine

Link

https://pubs.acs.org/doi/pdf/10.1021/acs.molpharmaceut.2c01069

Reference39 articles.

1. Fluorine-18 deoxyglucose and false-positive results: a major problem in the diagnostics of oncological patients

2. Comparative Evaluation of 18F-Labeled Glutamic Acid and Glutamine as Tumor Metabolic Imaging Agents

3. Synthesis and preliminary biological evaluation of S-11C-methyl-d-cysteine as a new amino acid PET tracer for cancer imaging

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Feasibility of [18F]fluoropivalate hybrid PET/MRI for imaging lower and higher grade glioma: a prospective first-in-patient pilot study;European Journal of Nuclear Medicine and Molecular Imaging;2023-07-25